Aurobindo Pharma Limited — Updates, 24-08-2026: General Updates
24-08-2026 | 09:01 am
24-08-2026 | 09:01 am
Aurobindo Pharma's US subsidiary, Lannett Company, concluded a US FDA inspection with four procedural observations. The company will respond promptly, reinforcing its commitment to robust quality and compliance standards.
No comments yet. Be the first to comment!
